1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LILLY(ELI) & CO
Lilly(Eli) & Co XNYS: LLY

Lilly(Eli) & Co Live Stock Price Today, Share Analysis and Chart

Expensive Performer
about

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumia...

Read More
742.91 5.08 (0.69%)
52W Low on Aug 08, 2025
2.4M
XNYS Volume

XNYS 04 Sep, 2025 4:17 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Lilly(Eli) & Co is on 08 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference See details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Expensive Valuation
28.5 / 100
Momentum Score
Technically Neutral
37.5 / 100
Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM
Analyst Price Target
889
1Yr Price target upside is 20%
27 analysts

8

S

7

W

1

O

2

T

SWOT Analysis

LillyEli Co Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..